| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |